ALDH1A1 and prostate carcinoma: Noteably, DU145 xenografts from galiellalactone treated mice showed reduced gene expression of ALDH1A1 compared to untreated DU145 xenografts indicating that galiellalactone may target prostate cancer stem cell-like cells also in vivo.